IPSEN Biopharmaceuticals Canada


Ipsen is a global specialty-driven biotechnology group with total sales exceeding €1.2 billion in 2014. Ipsen sells more than 20 drugs in more than 115 countries, with a direct commercial presence in more than 30 countries. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by 3 franchises: neurology, endocrinology and urology-oncology.


Ipsen Biopharmaceuticals Canada Inc. is driven by a passion to improve the lives of patients. A search for innovative solutions is at the heart of everything we do.


We are committed to finding innovative treatments in Oncology, Endocrinology and Neurology


From basic science to real-world treatments:

  • A comprehensive R&D approach anchored by a strong focus on peptides and toxins as our technological platform
  • A new state-of-the-art R&D facility opened in Cambridge, MA in July 2014


Ipsen Biopharmaceuticals Canada Inc. thrives on teamwork and collaboration, and we encourage our employees to innovate.
A vital part of our company culture is our close tie with our corporate headquarters in Basking Ridge and Paris, a tie that provides our employees with a rich global perspective and a broadened awareness of international cultures and business practices.
Ipsen Biopharmaceuticals Canada Inc. encourages employees to share best practices. We reward team players, and we facilitate and foster collaboration within our staff. Every person on our staff is important to us, and their ideas and insights are critical to our success. We are driven by accountability to customers and patients, and we strive for operational excellence and innovation.